It is reasonable to engage in a clinician-patient discussion with consideration of net risk reduction benefits of a PCSK9 mAb, as well as cost, administration by subcutaneous injection, the every 14-day or monthly dosing schedule, and, potentially, storage requirements (eg, refrigeration)
If baseline choline is low, KLOW binds to receptors but fails to produce the expected cognitive enhancement until endogenous choline levels rise
PCR products were directly sequenced with the Big-Dye Terminator Cycle v3.1 sequencing kit on an ABI 3100 sequencer (Applied Biosystems, Foster City, California), according to the manufacturer's instructions
How Clinicians Often Approach GLP-1 Treatment in Midlife Because response variability can increase during perimenopause and menopause, many clinicians take a structured approach when guiding GLP-1 treatment